Showing results (21-30 of 66) with videos related to
Sort By:
Pageof 7
Cell|April 17, 2026
Hallmarks of liver cancer: Therapeutic implicationsJosep M Llovet, Roser Pinyol, Silvia Affo, et al.Nature Reviews. Cancer|April 14, 2026
The versatile interplay between steatotic liver disease and liver cancerMohammad Rahbari, Albert Gris-Oliver, Pierluigi Ramadori, et al.Hepatology (Baltimore, Md.)|February 19, 2024
Stellate cell-specific adhesion molecule protocadherin 7 regulates sinusoidal contractionJames K Carter, Ming-Chao Tsai, Nicholas Venturini, et al.Cell Reports|January 19, 2022
The portrait of liver cancer is shaped by mitochondrial geneticsMrittika Chattopadhyay, Edmund Charles Jenkins, Ana Victoria Lechuga-Vieco, et al.Cancer Research|April 6, 2007
IFN-gamma enhances the antimyeloma activity of the fully human anti-human leukocyte antigen-DR monoclonal antibody 1D09C3Carmelo Carlo-Stella, Anna Guidetti, Massimo Di Nicola, et al.Gastroenterology|July 26, 2019
An Immune Gene Expression Signature Associated With Development of Human Hepatocellular Carcinoma Identifies Mice That Respond to Chemopreventive AgentsAgrin Moeini, Sara Torrecilla, Victoria Tovar, et al.Blood|January 16, 2010
Human CD34+ cells engineered to express membrane-bound tumor necrosis factor-related apoptosis-inducing ligand target both tumor cells and tumor vasculatureCristiana Lavazza, Carmelo Carlo-Stella, Arianna Giacomini, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 3, 2020
Copy-Number Alteration Burden Differentially Impacts Immune Profiles and Molecular Features of Hepatocellular CarcinomaLaia Bassaganyas, Roser Pinyol, Roger Esteban-Fabró, et al.British Journal of Cancer|July 10, 2019
Molecular portrait of high alpha-fetoprotein in hepatocellular carcinoma: implications for biomarker-driven clinical trialsRobert Montal, Carmen Andreu-Oller, Laia Bassaganyas, et al.Gastroenterology|May 13, 2022
NOTCH-YAP1/TEAD-DNMT1 Axis Drives Hepatocyte Reprogramming Into Intrahepatic CholangiocarcinomaShikai Hu, Laura Molina, Junyan Tao, et al.Pageof 7